Trough-level guided dosing is reliable for mycophenolate mofetil but not for enteric-coated mycophenolic sodium

被引:0
|
作者
Von Moos, Seraina [1 ]
Rho, Elena [2 ]
Lopez, Kai Castrezana [2 ]
Weidmann, Lukas [2 ]
George, Britta [2 ]
Pfister, Susan [2 ]
Schachtner, Thomas [2 ]
机构
[1] Cantonal Hosp Luzern, Luzern, Switzerland
[2] Univ Hosp Zurich, Div Nephrol, Zurich, Switzerland
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
2047
引用
收藏
页码:I1632 / I1633
页数:2
相关论文
共 50 条
  • [31] Enteric-coated mycophenolate sodium: Therapeutic equivalence to mycophenolate mofetil in de novo renal transplant patients
    Sollinger, H
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (02) : 517S - 520S
  • [32] Comparison of the exposure of mycophenolate mofetil and enteric-coated mycophenolate sodium in recipients of kidney-pancreas transplantation
    Belliere, Julie
    Esposito, Laure
    Gandia, Peggy
    Duffas, Jean Pierre
    Sallusto, Federico
    Cardeau-Desangles, Isabelle
    Del Bello, Arnaud
    Rostaing, Lionel
    Kamar, Nassim
    ANNALS OF TRANSPLANTATION, 2014, 19 : 76 - 81
  • [33] Efficacy and safety of conversion of mycophenolate mofetil to enteric-coated mycophenolate sodium in Mexican renal transplant children
    Reyes, H.
    Hernandez, A. M.
    Valverde, S.
    Cataneo, A.
    Mendoza, A.
    Barrera, I.
    Ortiz, L.
    Garcia-Roca, P.
    Lopez-Martinez, B.
    Castaneda-Hernandez, G.
    Medeiros, M.
    PEDIATRIC TRANSPLANTATION, 2010, 14 (06) : 746 - 752
  • [34] Three-Year Comparisons of Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil: Analysis of the Mycophenolic Acid Observational Renal Transplant (MORE) Registry.
    Chan, L.
    Shihab, F.
    Pankewycz, O.
    Doria, C.
    Wiland, A.
    Mccague, K.
    Langone, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 405 - 405
  • [35] Early Outcome Analysis of the Mycophenolic Acid Observational Renal Transplant (MORE) Registry: Initial Comparisons of Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil.
    Langone, A.
    Chan, L.
    Greenstein, S.
    Carson, R.
    Wiland, A.
    McCague, K.
    Doria, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 318 - 318
  • [36] Population pharmacokinetic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients.
    de Winter, B.
    van Gelder, T.
    Budde, K.
    Cattaneo, D.
    Tedesco-Silva, H.
    Neumann, I.
    Hilbrands, L.
    van Hest, R.
    Pescovitz, M.
    Mathot, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S61 - S61
  • [37] Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients
    Salvadori, M
    Holzer, H
    de Mattos, A
    Sollinger, H
    Arns, W
    Oppenheimer, F
    Maca, J
    Hall, M
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (02) : 231 - 236
  • [38] Enteric-coated mycophenolate sodium (EC-MPS) and mycophenolate mofetil (MMF), it is better to have the choice
    Budde, K
    Salvadori, M
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (05) : 1165 - 1166
  • [39] Use of enteric-coated mycophenolate sodium in liver transplant patients with intestinal intolerance caused by mycophenolate mofetil
    Doria, Cataldo
    Ramirez, Carlo B.
    Frank, Adam M.
    Vaccino, Silvia
    Fraser, Natalie
    Marino, Ignazio R.
    CLINICAL TRANSPLANTATION, 2009, 23 (06) : 882 - 886
  • [40] Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus
    Djabarouti, Sarah
    Duffau, Pierre
    Lazaro, Estibaliz
    Chapouly, Candice
    Greib, Carine
    Viallard, Jean-Francois
    Pellegrin, Jean-Luc
    Saux, Marie-Claude
    Breilh, Dominique
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (05) : 689 - 699